MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
MDT
95.62
+0.66%↑
VEEV
283
-3.27%↓
A
141.9
+0.66%↑
HQY
91.19
+0.35%↑
TLRY
1.55
+1.31%↑
24h
Current
Min
4.53
Max
4.83
Income | 182K -2.7M |
---|---|
Sales | -1.3M 2.1M |
EPS | -1.24 |
Profit margin | -131.697 |
Employees | 61 |
EBITDA | -535K -4M |
Recommendations | Buy |
---|---|
12 Months Forecast | +22.2% upside |
Market Cap | 1.5M 13M |
---|---|
Previous open | 9.76 |
Previous close | 4.58 |
By Trading Central
Confidence
Bearish Evidence
0.4084 / 0.4998 Support & Resistance
Past performance is not a reliable indicator of future results.
17 Oct 2025, 18:13 UTC
Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment
DJ
Read
17 Oct 2025, 17:05 UTC
Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked
DJ
Read
17 Oct 2025, 15:03 UTC
Obook Shares Sink Following Public Debut
DJ
Read
17 Oct 2025, 14:41 UTC
Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug
DJ
Read
17 Oct 2025, 23:25 UTC
New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com
DJ
Read
17 Oct 2025, 22:15 UTC
Ulta's CFO Appointment Seen Supporting Growth -- Market Talk
DJ
Read
17 Oct 2025, 21:15 UTC
Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk
DJ
Read
17 Oct 2025, 21:07 UTC
Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk
DJ
Read
17 Oct 2025, 21:07 UTC
Global Equities Roundup: Market Talk
DJ
Read
17 Oct 2025, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Read
17 Oct 2025, 20:34 UTC
Deere Is Reaching the End of Its Downcycle -- Market Talk
DJ
Read
17 Oct 2025, 20:27 UTC
Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk
DJ
Read
17 Oct 2025, 19:46 UTC
U.S. Natural Gas Futures Snap Losing Streak -- Market Talk
DJ
Read
17 Oct 2025, 19:45 UTC
Oil Futures Stabilize, But End Week With A Loss -- Market Talk
DJ
Read
17 Oct 2025, 18:45 UTC
Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk
DJ
Read
17 Oct 2025, 17:51 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Read
17 Oct 2025, 17:51 UTC
Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk
DJ
Read
17 Oct 2025, 17:44 UTC
EQT Seen With Long-Term Growth Opportunities -- Market Talk
DJ
Read
17 Oct 2025, 17:35 UTC
U.S. Oil Rig Count Unchanged at 418 -- Market Talk
DJ
Read
17 Oct 2025, 16:20 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Read
17 Oct 2025, 16:20 UTC
Basic Materials Roundup: Market Talk
DJ
Read
17 Oct 2025, 16:14 UTC
Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk
DJ
Read
17 Oct 2025, 16:04 UTC
Home Improvement Demand Is Starting to Pick Up -- Market Talk
DJ
Read
17 Oct 2025, 15:58 UTC
Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk
DJ
Read
17 Oct 2025, 15:56 UTC
These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com
DJ
Read
17 Oct 2025, 15:43 UTC
Global Equities Roundup: Market Talk
DJ
Read
17 Oct 2025, 15:43 UTC
Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk
DJ
Read
17 Oct 2025, 14:58 UTC
Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk
DJ
Read
17 Oct 2025, 14:41 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Read
17 Oct 2025, 14:35 UTC
American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 6 USD 22.2%
High 9.5 USD
Low 4 USD
Based on 3 Wall Street analysts offering 12 month price targets forEkso Bionics Holdings - Dist in the last 3 months.
By TipRanks
Buy
3 ratings
2
Buy
1
Hold
0
Sell
Based on 3 analysts giving stock ratings to Ekso Bionics Holdings - Dist in the past 3 months.
By Trading Central
Short Term
Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
No Evidence
There are no events.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$